Search for Clinical Trial Results

Sponsored By

Hemophilia - 93 Studies Found

Status Study
Terminated Study Name: Turkish Acquired Haemophilia Registry
Condition: Acquired Haemophilia
Date: 2011-07-26
Interventions: Drug: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin According to local clinical stan
Recruiting Study Name: Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Condition: Acquired Haemophilia
Date: 2012-10-16
Interventions:
  • Drug: Steroid + cyclophosphamide
  • Drug: Ste
Recruiting Study Name: Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A
Condition: Acquired Hemophilia A
Date: 2015-10-29
Interventions: Biological: OBIZUR Treating physician will determine treatment regimen, frequency of laboratory and clin
No longer available Study Name: Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
Condition: Acquired Hemophilia A
Date: 2013-10-21
Interventions: Biological: OBI-1 Other Name: B-Domain Deleted Recombinant Porcine Factor VIII
Completed Study Name: Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study
Condition:
  • Acquired Haemophilia
  • Register

Date: 2005-09-13
Completed Study Name: Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia
Condition:
  • Acquired Bleeding Disorder
  • Acquired Haemophilia

Date: 2011-01-26
Interventions: Drug: activated recombinant human factor VII Data collection of the use of activated recombinant human f
Terminated Study Name: Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
Condition: Hemophilia A
Date: 2006-03-23
Interventions:
  • Drug: Rituxan Acquired Hemophi
Completed Study Name: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A
Condition: Hemophilia A
Date: 2010-08-06
Interventions: Biological: OBI-1 Intravenous infusion
Completed Study Name: Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
Condition:
  • Congenital Bleeding Disorder
  • Congenital FVII Deficiency
  • Gl
    Date: 2008-06-11
    Interventions: Drug: eptacog alfa (activated) A NON INTERVENTIONAL OBSERV
Recruiting Study Name: Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
Condition: Haemophilia
Date: 2013-05-14
Next >>>